Angene Chemical
Draw
|
Currency :
Home Products

AG007Z1N

143201-11-0 | Cerivastatin, Sodium Salt

Chemical structure of Cerivastatin, Sodium Salt, CAS 143201-11-0
AG007Z1N
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 143201-11-0
Catalog Number AG007Z1N(AGN-PC-0PTNCW)
Chemical Name Cerivastatin, Sodium Salt
IUPAC Name sodium;(E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate
InChI InChI=1S/C26H34FNO5.Na/c1-15(2)25-21(11-10-19(29)12-20(30)13-23(31)32)24(17-6-8-18(27)9-7-17)22(14-33-5)26(28-25)16(3)4;/h6-11,15-16,19-20,29-30H,12-14H2,1-5H3,(H,31,32);/q;+1/p-1/b11-10+;/t19-,20-;/m1./s1
InChI Key GPUADMRJQVPIAS-QCVDVZFFSA-M
MDL Number MFCD20488047
Molecular Formula C26H33FNNaO5
Molecular Weight 481.5321
SMILES O=C([O-])C[C@H](O)C[C@H](O)/C=C/C1=C(C2=CC=C(F)C=C2)C(COC)=C(C(C)C)N=C1C(C)C.[Na+]
UNII 6Q18G1060S
Synonyms
6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, monosodium salt, (S-(R*,S*-(E)))-, 7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyrid-3-yl)-3,5-dihydroxy-6-heptenoate sodium salt, Bay w 6228, Baycol, cerivastatin, cerivastatin sodium, Certa, Kazak, Lipobay, rivastatin, CERIVASTATIN SODIUM, Baycol, Rivastatin, Lipobay, Certa, 143201-11-0, Bay w 6228, Cerivastatin sodium [USAN], CERIVASTATIN Na, UNII-6Q18G1060S, Bay-w-6228, CPD000469148, CHEBI:3559, 6Q18G1060S, (+)-Sodium (3R,5S,6E)-7-(4-(p-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl)-3,5-dihydroxy-6-heptenoate, 7-(4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyrid-3-yl)-3,5-dihydroxy-6-heptenoate sodium salt, Cerivastatin, sodium salt, DSSTox_CID_26488, DSSTox_RID_81659, DSSTox_GSID_46488, 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, monosodium salt, (S-(R*,S*-(E)))-, 6-Heptanoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-(S-(R*,S*-(E)))-, sodium salt, 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, monosodium salt, (3R,5S,6E)-, CAS-143201-11-0, NCGC00164625-02, Baycol (TN), bayw6228, C26H33FNNaO5, Rivastatin, Baycol, Lipobay, C26H33FNO5.Na, SCHEMBL41887, SCHEMBL41888, MLS001424071, CHEMBL1200563, DTXSID0046488, Cerivastatin sodium (JAN/USAN), GPUADMRJQVPIAS-QCVDVZFFSA-M, HMS2051H13, Tox21_112244, Tox21_303882, AKOS015967306, AKOS025149364, Tox21_112244_1, CCG-100954, NC00204, NCGC00164625-04, NCGC00357289-01, AN-31548, BC220457, LS-74656, SAM001246554, SMR000469148, D00889, A808034, J-007766, (3R,5S,6E)-7-[4-(4-Fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt, sodium (3R,5S,6E)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate, sodium (E,3R,5S)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]-3,5-dihydroxy-hept-6-enoate, sodium (E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate, sodium (E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-bis(oxidanyl)hept-6-enoate, sodium [S-[R*,S*-(E)]]-7-[4-(4-fluorophenyl)-5-methoxymethyl)-2,6bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate, cerivastatin, Kazak, C26H34FNO5.Na, C26-H34-F-N-O5.Na, CID5281100, C086276,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited